MEDS — Meds Apotek AB Cashflow Statement
0.000.00%
Consumer DefensivesMicro Cap
- SEK541.69m
- SEK503.58m
- SEK1.01bn
Annual cashflow statement for Meds Apotek AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -49.1 | -8.15 | -2.41 |
| Depreciation | |||
| Non-Cash Items | 0.047 | -0.036 | 20.6 |
| Other Non-Cash Items | |||
| Changes in Working Capital | -21.2 | 7.73 | -39.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -49.6 | 20.3 | -21.2 |
| Capital Expenditures | -8.68 | -8.23 | -7.61 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -0.13 | -0.298 | -0.367 |
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -8.81 | -8.52 | -7.98 |
| Financing Cash Flow Items | -2.86 | -0.203 | -9.3 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 84.3 | -41.2 | 53.2 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 25.8 | -29.4 | 24 |